STOCK TITAN

Petco Reports Fourth Quarter and Full Year 2025 Results

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

Petco (Nasdaq: WOOF) reported Q4 and full-year 2025 results on March 11, 2026, delivering profitability ahead of outlook and reducing leverage. FY2025 net sales were $6.0B (-2.5%), adjusted EBITDA rose to $408.2M (+21.3%), and net income was $9.1M versus a prior-year loss.

Cash increased to $256.7M after $95M voluntary debt paydown; the company completed debt refinancing to extend maturities to 2031 and provided FY2026 guidance of adjusted EBITDA $415M–$430M with net sales flat to +1.5%.

Loading...
Loading translation...

Positive

  • Adjusted EBITDA +21.3% to $408.2M in FY2025
  • Net income of $9.1M versus a $101.8M loss prior year
  • Leverage ratio improved from 4.2X to 3.0X by year-end 2025
  • Cash balance +$91.0M to $256.7M after debt paydown
  • Completed debt refinancing extending maturities to 2031

Negative

  • Net sales declined 2.5% to $6.0B in FY2025
  • Comparable sales decreased 1.6% year over year
  • Q4 net sales down 2.4% to $1.5B
  • Guidance expects net store closures of ~15–20 in 2026
  • Q1 2026 sales guidance: down 1% to flat year over year

Market Reaction – WOOF

+5.42% $2.53
15m delay 18 alerts
+5.42% Since News
+12.9% Peak in 3 min
$2.53 Last Price
$2.34 $2.88 Day Range
+$39M Valuation Impact
$766M Market Cap
0.8x Rel. Volume

Following this news, WOOF has gained 5.42%, reflecting a notable positive market reaction. Argus tracked a peak move of +12.9% during the session. Our momentum scanner has triggered 18 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $2.53. This price movement has added approximately $39M to the company's valuation.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.

Key Figures

Q4 2025 Net Sales: $1.5 billion (down 2.4%) Q4 2025 Adj. EBITDA: $106.3 million (up 10.6%) FY 2025 Net Sales: $6.0 billion (down 2.5%) +5 more
8 metrics
Q4 2025 Net Sales $1.5 billion (down 2.4%) Fourth quarter 2025 vs. Q4 2024; comps down 1.6%
Q4 2025 Adj. EBITDA $106.3 million (up 10.6%) Fourth quarter 2025; described as well above outlook
FY 2025 Net Sales $6.0 billion (down 2.5%) Full year 2025 vs. full year 2024; comps down 1.6%
FY 2025 Net Income $9.1 million Full year 2025 vs. $101.8 million loss in 2024
Free Cash Flow 2025 $187.0 million (up 276.3%) Full year 2025 vs. prior year level
Total Secured Debt ~$1.5 billion End of 2025, down from $1.595 billion last year
FY 2026 Adj. EBITDA Outlook $415–$430 million Full year 2026 guidance range
FY 2026 Net Sales Outlook Flat to up 1.5% Full year 2026 year-over-year net sales guidance

Market Reality Check

Price: $2.40 Vol: Volume 2,854,949 is 1.69x...
high vol
$2.40 Last Close
Volume Volume 2,854,949 is 1.69x the 20-day average of 1,694,110 ahead of earnings. high
Technical Price at $2.33 is trading below the 200-day moving average of $3.12 and 48.28% under the 52-week high.

Peers on Argus

Scanner data flags WOOF moving up with elevated volume while only one peer, BBW,...
1 Up

Scanner data flags WOOF moving up with elevated volume while only one peer, BBW, also screens higher (~2.82%). Other specialty retail peers show smaller moves, suggesting this earnings release is driving a stock-specific reaction rather than a broad sector shift.

Previous Earnings Reports

5 past events · Latest: Nov 25 (Positive)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Nov 25 Q3 2025 earnings Positive +14.5% Q3 2025 results with margin expansion and raised fiscal 2025 earnings outlook.
Aug 28 Q2 2025 earnings Positive +23.5% Q2 2025 profitability gains, margin expansion, and higher adjusted EBITDA guidance.
Jun 05 Q1 2025 earnings Positive -23.3% Q1 2025 sales decline but better margins and improved operating income and EBITDA.
Mar 26 FY 2024 earnings Positive +31.6% Q4 and FY 2024 results with smaller GAAP loss and cash flow metrics disclosed.
Dec 05 Q3 2024 earnings Positive +8.0% Q3 2024 revenue growth, improved gross profit, and higher adjusted EBITDA.
Pattern Detected

Earnings releases have often been followed by strong moves, mostly positive when profitability and guidance improved, with one notable divergence where shares fell despite better margins.

Recent Company History

Over the last five earnings updates from Dec 2024 through Nov 2025, Petco repeatedly reported modest revenue pressure but steady margin expansion and improving profitability. The company raised or reaffirmed earnings guidance multiple times and highlighted adjusted EBITDA growth and cost discipline. Share price reactions were frequently strong, with several double-digit gains following earnings reports. Today’s fourth quarter and full year 2025 results continue themes of higher margins, improved adjusted EBITDA, and a focus on leverage and cash generation versus top-line growth.

Historical Comparison

+10.8% avg move · Across the last 5 earnings releases, WOOF saw an average move of about 10.84%, with most reports hig...
earnings
+10.8%
Average Historical Move earnings

Across the last 5 earnings releases, WOOF saw an average move of about 10.84%, with most reports highlighting margin expansion and improving adjusted EBITDA.

Earnings updates from late 2024 through 2025 show a progression from sizable GAAP losses toward improved profitability, with recurring themes of gross margin expansion, rising adjusted EBITDA, tighter cost control, and more detailed full-year guidance framing the company’s turnaround narrative.

Market Pulse Summary

The stock is up +5.4% following this news. A strong positive reaction aligns with Petco’s pattern of...
Analysis

The stock is up +5.4% following this news. A strong positive reaction aligns with Petco’s pattern of sizable moves around earnings, where prior reports often paired modest sales pressure with clear profitability gains. This release highlighted higher gross margins, rising Adjusted EBITDA, improved net income, and stronger free cash flow alongside lower secured debt. Elevated short-term enthusiasm could face risks from the flat-to-low growth 2026 sales outlook and the need to sustain margin improvements over time.

Key Terms

adjusted ebitda, free cash flow, leverage ratio, capital expenditures, +4 more
8 terms
adjusted ebitda financial
"Adjusted EBITDA1 increased 10.6% to $106.3 million, well above the Company's outlook."
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
free cash flow financial
"Free cash flow1 was $187.0 million, an increase of $137.3 million or 276.3% above last year."
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
leverage ratio financial
"goal of lowering our leverage ratio1 from 4.2X when we entered the year to 3X"
Leverage ratio measures how much a company relies on borrowed money compared with its own funds or assets, typically expressed as debt relative to equity or total assets. Like a homeowner with a mortgage, higher leverage can amplify returns when business is strong but also raises the chance of big losses or default if revenue falls, so investors use it to judge financial risk and resilience.
capital expenditures financial
"Capital Expenditures | ~$140 million"
Capital expenditures are the money a company spends to buy or improve big assets like buildings, equipment, or machines that will last a long time. These investments matter because they help the company grow and operate more efficiently, similar to how upgrading a home’s appliances or adding a new room can make it better and more valuable.
depreciation & amortization financial
"Depreciation & Amortization | ~$200 million"
Depreciation & amortization are accounting methods that spread the cost of a long‑lived asset over the years it is expected to be useful: depreciation applies to physical items like machinery or buildings, while amortization applies to intangible items like patents or software. They matter to investors because they reduce reported profit each period without an immediate cash outlay, much like budgeting the gradual wear and replacement of a car, so they help reveal true earnings, cash flow and future capital needs.
non-gaap financial measures financial
"Adjusted EBITDA, Free Cash Flow, and Leverage Ratio are non-GAAP financial measures."
Non-GAAP financial measures are numbers companies use to show their financial performance that exclude certain expenses or income. They help investors see how the company might perform without one-time costs or other unusual items, giving a different perspective from official reports. However, since they can be adjusted, they don’t always tell the full story and should be looked at alongside standard financial figures.
basis points financial
"gross margin increased 37 basis points to 38.3%."
Basis points are a way to measure small changes in interest rates or percentages, where one basis point equals 0.01%. For example, if a loan's interest rate increases by 50 basis points, it's gone up by 0.50%. They help people understand tiny differences in rates that can add up over time, making financial comparisons clearer.
net interest expense financial
"Net Interest Expense | ~$125 million"
Net interest expense is the amount a company pays in interest on its borrowings after subtracting the interest it earns on cash and investments; it’s effectively the company’s net cost of borrowing. Investors watch it because it reduces profits and cash available for dividends or growth, and it can rise or fall with interest rates and how much debt a company carries—think of it like your household mortgage payments minus any interest you get from savings.

AI-generated analysis. Not financial advice.

Delivers Profitability Ahead of Outlook, Reduces Leverage Ratio
Provides Fiscal 2026 Outlook*

SAN DIEGO, March 11, 2026 /PRNewswire/ -- Petco (Nasdaq: WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today reported its fourth quarter and full year 2025 financial results.

"In fiscal 2025, we strengthened our leadership team and rebuilt the foundation of our economic model, enabling us to exceed our profitability goals," said Joel Anderson, Chief Executive Officer of Petco. "With that work largely complete, we are entering the next phase of our strategy focused on driving sustainable, profitable top‑line growth."

Anderson continued, "As we look ahead, we see significant opportunities across core consumables, supplies and services.  We are confident that our focus on driving product newness and innovation as well as leveraging our differentiated, high touch store ecosystem will help us to grow market share.  Our outlook reflects our strategic initiatives and assumes a return to positive comps in 2026."

Q4 2025 Overview

For the fourth quarter of 2025 compared to the fourth quarter of 2024:

  • Net sales of $1.5 billion decreased 2.4%; comparable sales decreased 1.6%.
  • Gross profit decreased 1.4% to $580.8 million and gross margin increased 37 basis points to 38.3%
  • Operating income increased 83.2% to $31.9 million; operating margin increased 98 basis points to 2.1%.
  • Net loss of $2.6 million versus a loss of $13.8 million.
  • Adjusted EBITDA1 increased 10.6% to $106.3 million, well above the Company's outlook.
  • The Company closed 7 net stores, ending the year with 1,382 stores.

Full Year 2025 Overview

For the full year 2025 compared to the full year of 2024:

  • Net sales of $6.0 billion decreased 2.5%; comparable sales decreased 1.6%.
  • Gross profit decreased 0.8% to $2.3 billion and gross margin increased 66 basis points to 38.7%
  • Operating income increased to $120.4 million from $7.1 million; operating margin increased 190 basis points to 2.0%.
  • Net income of $9.1 million, up from a loss of $101.8 million.
  • Adjusted EBITDA1 increased 21.3% to $408.2 million, above the Company's outlook.

Sabrina Simmons, Chief Financial Officer of Petco, added, "Petco once again delivered on our commitments while building a stronger foundation, improving profitability and cash generation through our economic model. These results enabled significant progress in achieving our goal of lowering our leverage ratio1 from 4.2X when we entered the year to 3X at the end of 2025.  As we enter this next phase of growth, we see ongoing opportunity to improve our financial strength."

Full Year 2025 Balance Sheet and Cash Flow

  • Cash grew by $91.0 million to $256.7 million after voluntarily paying down $95.0 million in debt. 
  • Inventory fell 9.7% versus the 2.5% decline in sales.
  • Cash from operations rose by $136.4 million or 76.8% to $314.1 million.
  • Free cash flow1 was $187.0 million, an increase of $137.3 million or 276.3% above last year.
  • Total secured debt was ~$1.5 billion, down from $1.595 billion last year.
  • The Company completed the refinancing of its debt on February 2, extending its maturities to 2031 and providing ample flexibility through a mix of fixed and floating rate instruments consisting of a $900 million variable rate term loan and $600 million fixed rate bond.  

2026 Guidance

For fiscal 2026 and Q1, the Company is providing guidance as follows.

Full Year 2026 Outlook


FY 2026 Outlook*

    Net Sales

Flat to up 1.5% year over year

    Adjusted EBITDA1

$415 million to $430 million

    Net Interest Expense

~$125 million

    Capital Expenditures

~$140 million

    Depreciation & Amortization

~$200 million

    Net Store Closures

~15-20

First Quarter 2026 Outlook


Q1 2026 Outlook*

    Net Sales

Down 1% to flat year over year

Adjusted EBITDA1

$92 million to $94 million

*Assumptions in the outlook include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent, and that current or planned tariffs on imports into the U.S. from other countries remain at March 11, 2026 levels.  Additionally, our outlook assumes that fuel prices normalize by the end of the quarter.  Adjusted EBITDA is a non-GAAP financial measure and has not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

(1)

Adjusted EBITDA, Free Cash Flow, and Leverage Ratio are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

Earnings Conference Call Webcast Information:
Management will host an earnings conference call on March 11, 2026 at approximately 4:30 PM Eastern Time to discuss the company's financial results. A live webcast of the conference call will be available on the company's Investor Relations page at https://ir.petco.com/news-and-events/events-and-presentations. A replay of the webcast will be available through the same link approximately two hours after the conference call. 

About Petco:  

We're proud to be "where the pets go" to find everything they need to live their best lives for more than 60 years — from their favorite meals and toys, to trusted supplies and expert support from people who get it, because we live it. We believe in the universal truths of pet parenthood — the boundless boops, missing slippers, late night zoomies and everything in between. And we're here for it. Every tail wag, every vet visit, every step of the way. We nurture the pet-human bond in the aisles of more than 1,500 Petco stores across the U.S., Mexico and Puerto Rico. Customers experience our exclusive selection of pet care products, services, expertise and membership offerings in stores and online at petco.com, and on the Petco app. In 1999, we founded Petco Love. Together, we support thousands of local animal welfare groups nationwide and have helped find homes for over 7 million animals through in-store adoption events.

Forward-Looking Statements:

This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including, but not limited to, statements regarding our Q1 and full year 2026 outlook, operational reset of our business, our competitive positioning, profitability, cash generation through our economic model, expense leverage, operating margin expansion, cost action plans and associated cost-savings, our path to sustainable, profitable growth and our expectations regarding tariffs and associated impacts. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. These statements are only predictions based on our current expectations and projections about future events and reflect our beliefs regarding such future events and do not represent historical facts or statements of current condition. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers, mass and grocery retailers, and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation, prevailing interest rates and the impact of tariffs; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflicts in Ukraine and the Middle East), government shutdowns, health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; (xx) impairments of the carrying value of our goodwill and other intangible assets; (xxi) our ability to successfully implement our operational adjustments, achieve the expected benefits of our cost action plans and drive improved profitability; (xxii) our ability to deliver sustainable, profitable growth and (xxiii) the other risks, uncertainties and other factors identified under "Risk Factors" in our most recent Annual Report on Form 10-K  and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)













13 Weeks Ended


52 Weeks Ended




January 31,
2026


February 1,
2025


January 31,
2026


February 1,
2025


Net sales:










Products


$     1,259,226


$     1,310,217


$     4,936,323


$     5,116,891


Services and other


255,902


241,913


1,025,144


999,571


Total net sales


1,515,128


1,552,130


5,961,467


6,116,462


Cost of sales:










Products


775,588


811,204


3,028,909


3,173,269


Services and other


158,770


151,666


627,486


618,791


Total cost of sales


934,358


962,870


3,656,395


3,792,060


Gross profit


580,770


589,260


2,305,072


2,324,402


Selling, general and administrative expenses


548,914


571,872


2,184,639


2,317,351


Operating income


31,856


17,388


120,433


7,051


Interest income


(2,223)


(1,278)


(6,305)


(3,714)


Interest expense


31,581


34,111


131,199


143,531


Loss on extinguishment and modification of debt


565



565



Other non-operating loss (income)



1,000



(4,800)


Income (loss) before income taxes and income from
   equity method investees


1,933


(16,445)


(5,026)


(127,966)


Income tax expense (benefit)


11,301


2,504


6,266


(7,481)


Income from equity method investees


(6,793)


(5,112)


(20,358)


(18,669)


Net (loss) income attributable to Class A and B-1 common
   stockholders


$              (2,575)


$           (13,837)


$               9,066


$         (101,816)












Net (loss) income per Class A and B-1 common share:










Basic


$            (0.01)


$            (0.05)


$             0.03


$            (0.37)


Diluted


$            (0.01)


$            (0.05)


$             0.03


$            (0.37)












Weighted average shares used in computing net (loss) income per Class A
   and B-1 common share:










Basic


281,236


276,305


279,555


273,410


Diluted


281,236


276,305


286,148


273,410


 

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)






 January 31,
2026 


 February 1,
2025 

ASSETS





Current assets:





Cash and cash equivalents


$    256,736


$    165,756

Receivables, less allowance for credit losses1


45,812


40,425

Merchandise inventories, net


590,210


653,329

Prepaid expenses


51,747


53,515

Other current assets


75,281


60,594

Total current assets


1,019,786


973,619

Fixed assets, net


656,148


725,438

Operating lease right-of-use assets


1,288,593


1,302,346

Goodwill


980,064


980,064

Trade name


1,025,000


1,025,000

Other long-term assets


203,834


187,963

Total assets


$  5,173,425


$  5,194,430

LIABILITIES AND EQUITY





Current liabilities:





Accounts payable and book overdrafts


$    450,552


$    492,878

Accrued salaries and employee benefits


154,148


157,460

Accrued expenses and other liabilities


204,751


177,079

Current portion of operating lease liabilities


320,082


306,400

Current portion of long-term debt and other lease liabilities


4,608


5,346

Total current liabilities


1,134,141


1,139,163

Senior secured credit facilities, net, excluding current portion


1,488,527


1,578,091

Operating lease liabilities, excluding current portion


1,047,185


1,037,206

Deferred taxes, net


234,911


217,712

Other long-term liabilities


104,407


108,628

Total liabilities


4,009,171


4,080,800

Commitments and contingencies





Stockholders' equity:





Class A common stock2


244


239

Class B-1 common stock3


38


38

Class B-2 common stock4



Preferred stock5



Additional paid-in-capital


2,312,354


2,280,495

Accumulated deficit


(1,139,993)


(1,149,059)

Accumulated other comprehensive loss


(8,389)


(18,083)

Total stockholders' equity


1,164,254


1,113,630

Total liabilities and stockholders' equity


$  5,173,425


$  5,194,430


1 Allowances for credit losses are $779 and $1,594, respectively

2 Class A common stock, $0.001 par value: Authorized - 1.0 billion shares;
        Issued and outstanding - 243.7  million and 239.1 million shares, respectively

3 Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares;
        Issued and outstanding - 37.8 million shares

4 Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares;
        Issued and outstanding - 37.8 million shares

5 Preferred stock, $0.001 par value: Authorized - 25.0 million shares;
        Issued and outstanding - none

 

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited and subject to reclassification)








52 Weeks Ended



January 31,
2026


February 1,
2025

Cash flows from operating activities:





Net income (loss)


$        9,066


$   (101,816)

Adjustments to reconcile net income (loss) to net cash provided by
  operating activities:





Depreciation and amortization


196,710


208,517

Amortization of debt discounts and issuance costs


5,022


4,896

Provision for deferred taxes


17,050


(30,492)

Equity-based compensation expense


32,650


50,212

Loss on extinguishment and modification of debt


565


Income from equity method investees


(20,358)


(18,669)

Amounts reclassified out of accumulated other comprehensive loss


(556)


(3,146)

Non-cash operating lease costs


411,812


414,396

Other non-operating income



(4,800)

Changes in assets and liabilities:





Receivables


(5,621)


4,178

Merchandise inventories


63,119


30,767

Prepaid expenses and other assets


818


(3,960)

Accounts payable and book overdrafts


(42,992)


8,484

Accrued salaries and employee benefits


(3,271)


56,981

Accrued expenses and other liabilities


24,987


(12,455)

Operating lease liabilities


(371,134)


(418,219)

Other long-term liabilities


(3,817)


(7,201)

Net cash provided by operating activities


314,050


177,673

Cash flows from investing activities:





Cash paid for fixed assets


(127,097)


(127,990)

Cash paid for acquisitions, net of cash acquired



(629)

Cash paid for investments



(457)

Proceeds from investment



998

Proceeds from sale of assets


2,541


1,369

Cash received from partial surrender of officers' life insurance



2,806

Net cash used in investing activities


(124,556)


(123,903)

Cash flows from financing activities:





Borrowings under long-term debt agreements



201,000

Repayments of long-term debt


(95,250)


(201,000)

Debt refinancing costs



(3,028)

Payments for finance lease liabilities


(5,614)


(5,707)

Proceeds from employee stock purchase plan and stock option exercises


3,677


3,770

Tax withholdings on stock-based awards


(4,560)


(6,289)

Proceeds from issuance of common stock 



2,500

Net cash used in financing activities


(101,747)


(8,754)






Net decrease in cash, cash equivalents and restricted cash


87,747


45,016

Cash, cash equivalents and restricted cash at beginning of period


181,665


136,649

Cash, cash equivalents and restricted cash at end of period


$    269,412


$    181,665

NON-GAAP FINANCIAL MEASURES

The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

Adjusted EBITDA

Adjusted EBITDA is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended February 1, 2025 filed with the SEC on March 31, 2025 for additional information on Adjusted EBITDA.

The table below reflects the calculation of Adjusted EBITDA for the thirteen and fifty-two weeks ended January 31, 2026 compared to the thirteen and fifty-two weeks ended February 1, 2025.

(dollars in thousands)


13 Weeks Ended


52 Weeks Ended

Reconciliation of Net (Loss) Income Attributable to Class A and B-1
   Common Stockholders to Adjusted EBITDA


January 31,
2026


February 1,
2025


January 31,
2026


February 1,
2025

Net (loss) income attributable to Class A and B-1 common stockholders


$         (2,575)


$       (13,837)


$              9,066


$       (101,816)

Add (deduct):









Interest expense, net


29,358


32,833


124,894


139,817

Income tax expense (benefit) 


11,301


2,504


6,266


(7,481)

Depreciation and amortization


47,567


50,654


196,710


208,517

Income from equity method investees


(6,793)


(5,112)


(20,358)


(18,669)

Loss on debt extinguishment and modification


565



565


Equity-based compensation expense


7,278


9,507


32,650


50,212

Other non-operating loss (income)



1,000



(4,800)

Mexico joint venture EBITDA (1)


13,915


11,233


46,135


41,615

Acquisition and divestiture-related integration costs (2)





3,719

Other costs (3)


5,678


7,341


12,239


25,412

Adjusted EBITDA


$      106,294


$        96,123


$          408,167


$        336,526

Net sales


$  1,515,128


$  1,552,130


$    5,961,467


$   6,116,462

Net margin (4)


(0.2 %)


(0.9 %)


0.2 %


(1.7 %)

Adjusted EBITDA Margin


7.0 %


6.2 %


6.8 %


5.5 %



(1)

Mexico joint venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.

 



13 Weeks Ended


52 Weeks Ended

(in thousands)


January 31,
2026


February 1,
2025


January 31,
2026


February 1,
2025

Net income


$      13,586


$      10,224


$      40,715


$      37,559

Depreciation


7,819


6,536


28,934


27,360

Income tax expense


5,668


5,014


18,267


16,010

Foreign currency (gain) loss


(225)


176


772


169

Interest expense, net


982


516


3,581


2,131

EBITDA


$      27,830


$      22,466


$      92,269


$      83,229

50% of EBITDA


$        13,915


$        11,233


$        46,135


$        41,615



(2)

Acquisition and divestiture-related integration costs include direct costs resulting from acquiring, integrating, or divesting businesses. These include third-party professional and legal fees, losses on sales of divestitures, and other integration-related costs that would not have otherwise been incurred as part of the company's operations.



(3)

Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions. In fiscal 2025, other costs were primarily driven by $9.7 million of severance and $2.5 million relating to legal matters. In fiscal 2024, other costs were primarily driven by $15.8 million of severance and $7.7 million relating to legal matters and strategic initiatives.



(4)

We define net margin as net loss attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

Free Cash Flow

Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.

The table below reflects the calculation of Free Cash Flow for the thirteen and fifty-two weeks ended January 31, 2026 compared to the thirteen and fifty-two weeks ended February 1, 2025.

(in thousands)


13 Weeks Ended


52 Weeks Ended



January 31,
2026


February 1,
2025


January 31,
2026


February 1,
2025

Net cash provided by operating activities


$    153,522


$       95,993


$     314,050


$     177,673

Cash paid for fixed assets


(37,137)


(36,949)


(127,097)


(127,990)

Free Cash Flow


$     116,385


$       59,044


$     186,953


$       49,683

Leverage Ratio

Leverage Ratio is a non-GAAP financial measure that is calculated as net debt divided by Adjusted EBITDA.

The table below reflects the calculation for Leverage Ratio for the fifty-two weeks ended January 31, 2026 compared to the fifty-two weeks ended February 1, 2025.

(dollars in thousands)


January 31,
2026


February 1,
2025

Total debt:





Senior secured credit facilities, net, including current portion


$       1,488,527


$       1,578,091

Finance leases, including current portion


9,683


13,793

Total debt


1,498,210


1,591,884

Less: cash and cash equivalents


(256,736)


(165,756)

Net Debt


$      1,241,474


$      1,426,128

Adjusted EBITDA


$         408,167


$         336,526

Net Debt / Adjusted EBITDA ratio


3.0x


4.2x

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-reports-fourth-quarter-and-full-year-2025-results-302711280.html

SOURCE Petco - Investor Relations

FAQ

What were Petco (WOOF) full-year 2025 net sales and growth?

Petco reported full-year 2025 net sales of $6.0 billion, down 2.5% year over year. According to the company, comparable sales declined 1.6% and gross margin expanded 66 basis points to 38.7%.

How much did Petco (WOOF) improve adjusted EBITDA in FY2025?

Adjusted EBITDA increased to $408.2 million, a 21.3% rise versus the prior year. According to the company, this result came in above its outlook and supported stronger cash generation.

What debt and liquidity changes did Petco (WOOF) report on March 11, 2026?

Petco increased cash to $256.7 million and paid down $95.0 million of debt in 2025. According to the company, it completed refinancing to extend maturities to 2031 and reduced secured debt to about $1.5 billion.

What is Petco's (WOOF) full-year 2026 guidance for sales and adjusted EBITDA?

For fiscal 2026 Petco guides net sales flat to up 1.5% and adjusted EBITDA of $415M–$430M. According to the company, outlook assumes stable economic and currency conditions and normalized fuel prices.

What does Petco's (WOOF) short-term outlook say about Q1 2026 performance?

Q1 2026 guidance calls for net sales down 1% to flat and adjusted EBITDA of $92M–$94M. According to the company, assumptions include consistent tariffs and expected fuel price normalization by quarter end.
Petco Health & Wellness Company, Inc.

NASDAQ:WOOF

View WOOF Stock Overview

WOOF Rankings

WOOF Latest News

WOOF Latest SEC Filings

WOOF Stock Data

655.30M
86.34M
Specialty Retail
Retail-retail Stores, Nec
Link
United States
SAN DIEGO